Funding Received
$73.9 Million in 5 Rounds from 4 Investors
Most Recent Funding
$20.5 Million Debt Financing on February 25, 2013
Headquarters:
Lexington, MA
Description:
Pulmatrix develops inhaled therapies for the treatment, prevention and transmission of infectious and progressive respiratory diseases.
Founders:
Mark J. Gabrielson, Alexander Klibanov, Robert S. Langer
Categories:
Biotechnology
Website:
http://www.pulmatrix.com

Company Details

Update

Pulmatrix, Inc., a clinical stage biopharmaceutical company, develops inhaled therapies for the treatment, prevention, and transmission control of infectious and progressive respiratory diseases. It offers inhaled cationic airway lining modulator drugs, which stimulate host defense mechanisms within the airway to treat and prevent influenza, rhinovirus, and chronic pulmonary diseases. The company was founded in 2003 and is based in Lexington, Massachusetts.

Funding Rounds (5) - $73.9M

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    99 Hayden Avenue

    Suite 390

    Lexington, MA 02421

    USA

Images (1)

Update
  • 561fe7262da97f208ec78e42f06e7ab6